相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Challenges for Clinical Drug Development in Pulmonary Fibrosis
Eric S. White et al.
FRONTIERS IN PHARMACOLOGY (2022)
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry
Wim A. Wuyts et al.
PULMONARY THERAPY (2022)
Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European Survey
Iris G. van Der Sar et al.
FRONTIERS IN MEDICINE (2021)
Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations
Annelise Roennow et al.
BMJ OPEN (2020)
ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
Michael T. Durheim et al.
BMJ OPEN RESPIRATORY RESEARCH (2020)
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Vincent Cottin
EUROPEAN RESPIRATORY REVIEW (2019)
The therapy of idiopathic pulmonary fibrosis: what is next?
Vivien Somogyi et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Diagnostic test interpretation and referral delay in patients with interstitial lung disease
David Pritchard et al.
RESPIRATORY RESEARCH (2019)
Fibrosing interstitial lung diseases: knowns and unknowns
Vincent Cottin et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey
Gregory P. Cosgrove et al.
BMC PULMONARY MEDICINE (2018)
Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis
Joanna C. Crocker et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes
David Haerry et al.
FRONTIERS IN MEDICINE (2018)
Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury
Thomas H. Sisson et al.
PHYSIOLOGICAL REPORTS (2018)
Simulating clinical trial visits yields patient insights into study design and recruitment
S. Sam Lim et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Optimizing quality of life in patients with idiopathic pulmonary fibrosis
Mirjam J. G. van Manen et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2017)
Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD
Kristen E. Holm et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2016)
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action
Anton Hoos et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2015)
Delayed Access and Survival in Idiopathic Pulmonary Fibrosis A Cohort Study
Daniela J. Lamas et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
分享论文
